Recent trial data demonstrate that these benefits extend to individuals without diabetes, underscoring their role as cardiometabolic therapies rather than purely glucose-lowering medications [50, 51]
For a product that claims to deliver pharmaceutical compounds through your skin, the absence of basic business transparency is alarming
The full length N-terminal extended forms of GLP-1 (137 and 136) are biologically inert
Too much doesnt work faster
The goal is to ensure intravenous support is offered only when appropriate and likely to provide meaningful benefit
Patients with these risk factors should discuss screening and supplementation strategies with their GP, particularly if experiencing symptoms such as fatigue, paraesthesia, glossitis, or cognitive changes suggestive of deficiency